Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis

@article{Mehrotra2019ComparativeEO,
  title={Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis},
  author={Rajnish Mehrotra and Daniel Cukor and Mark Unruh and Tessa C. Rue and Patrick J. Heagerty and Scott D. Cohen and Laura M. Dember and Yaminette Diaz-Linhart and Amelia N. Dubovsky and Tom Greene and Nancy K. Grote and Nancy Kutner and Madhukar H. Trivedi and Davin K. Quinn and Nisha ver Halen and Steven Darrow Weisbord and Bessie Ann Young and Paul L. Kimmel and S. Susan Hedayati},
  journal={Annals of Internal Medicine},
  year={2019},
  volume={170},
  pages={369-379}
}
Worldwide, the number of persons with end-stage renal disease who are receiving maintenance hemodialysis is increasing (1). Approximately one third of these patients have depressive symptoms, and patients rank depression as a top-priority condition for which effective treatments need to be identified (2, 3). Cardinal manifestations of major depressive disorder, such as anorexia, insomnia, and fatigue, also are common among persons receiving hemodialysis. These symptoms contribute to poor health… Expand
ASCENDing to New Heights in Our Understanding of the Treatment of Depression Among Individuals Receiving Hemodialysis
TLDR
A 2-phase randomized controlled trial in patients receiving hemodialysis evaluated the effects of sertraline treatment versus chairside CBT on the severity of depressive symptoms and the importance of patientclinician communication about depressive symptoms, regardless of intervention. Expand
ASCENDing to NewHeights in Our Understanding of the Treatment of Depression Among Individuals ReceivingHemodialysis
  • 2019
Depression Among Individuals Receiving Hemodialysis D is the most common psychiatric condition among patients receiving maintenance hemodialysis. Depression negatively affects functional status andExpand
Comparing the Effectiveness of Depression Treatments for Patients Undergoing Maintenance Hemodialysis
  • Medicine
  • Annals of Internal Medicine
  • 2019
TLDR
After comparing the group interviewed by a therapist with the group that received only general information about depression, the researchers found no difference in the proportion of patients who agreed to start depression treatment, and depression scores improved in both the CBT and sertraline groups, improvement was slightly greater among the patients who received sERTraline. Expand
Pharmacologic and psychological interventions for depression treatment in patients with kidney disease.
TLDR
Although the data do not support unlimited use of SSRIs in patients with CKD or end-stage kidney disease, it is reasonable to initiate a cautious trial of sertraline while closely monitoring for depressive symptom improvement and adverse effects. Expand
Treatment Options for Depression in Patients with Chronic Renal Disease and End-Stage Renal Disease on Dialysis: A Mini Review of Clinical Trials and Meta-Analysis
Chronic renal failure and end stage renal failure is an established healthcare issue with a growing prevalence. Depression is particularly common in the already physically and mentally morbid patientExpand
Depression in dialysis
  • N. Tian, Na Chen, P. Li
  • Medicine
  • Current opinion in nephrology and hypertension
  • 2021
TLDR
Depression management through early screening and continuous care models emphasizing dynamic relationships between healthcare teams, patients and families should be encouraged and large-scale studies of short-term and long-term benefits of pharmacological and nonpharmacological depression management are warranted. Expand
The landscape of psychiatric illness in CKD and ESRD
TLDR
It is necessary to link outcomes of therapy of psychiatric disorders to hard outcomes such as improved survival, in patients with CKD and ESRD, as treatment may be associated with improvement in quality and quantity of life. Expand
Depression in patients with CKD and ESRD
TLDR
The major screening instruments used and the nonpharmacological approaches to treating comorbid depression in ESRD patients, focusing on cognitive behavioral therapy and exercise interventions are discussed. Expand
Psychological Flexibility: A Novel Risk Factor for Depression in Kidney Disease
TLDR
A multicenter study of participants from Japan, including individuals with advanced (stages 3-5) CKD and with endstage kidney disease (ESKD) requiring dialysis, finds improvements in scores after undergoing CBT are associated with clinical improvement in depression. Expand
Mental health status and quality of life in patients with end-stage renal disease undergoing maintenance hemodialysis.
TLDR
Prealbumin, type 2 diabetes mellitus, heart rate, educational level, duration of hemodialysis, coronary artery disease, heart failure, marital status, hemoglobin A1C, hemoxide were significantly associated with poorer mental health status of ESRD patients undergoing maintenance hemodIALysis, and patients with poorer psychological states were more significantlyassociated with decreased QOL. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Acceptance of Antidepressant Treatment by Patients on Hemodialysis and Their Renal Providers.
TLDR
Patients on chronic hemodialysis with depression are frequently not interested in modifying or initiating antidepressant treatment, commonly attributing their depression to a recent acute event, chronic illness, or dialysis, and renal providers are often unwilling to modify or initiate antidepressant therapy. Expand
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).
TLDR
The rationale and design of ASCEND, the first large-scale randomized controlled trial evaluating efficacy of non-pharmacologic vs. pharmacologic treatment of depression in HD patients for patient-centered outcomes, are discussed. Expand
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial
TLDR
Among patients with non–dialysis-dependent CKD and MDD, treatment with sertraline compared with placebo for 12 weeks did not significantly improve depressive symptoms, and these findings do not support the use of sERTraline to treat MDD in patients withNon– Dialysis- dependent CKD. Expand
Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe.
TLDR
Self-reported depression by two simple questions was associated with increased risks of mortality and hospitalization for hemodialysis patients. Expand
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
TLDR
The rationale and design of the CAST study is discussed, the largest placebo-controlled trial aimed to establish safety and efficacy of a SSRI in the acute phase treatment of CKD patients with MDD. Expand
Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients.
TLDR
It is suggested that a depressive affect is an important contributor to low medication adherence in patients with ESRD on hemodialysis or kidney transplant recipients and the only statistically significant predictor of medication adherence beyond gender and mode of treatment. Expand
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
TLDR
Evidence for antidepressant medication in the dialysis setting is sparse and data are generally inconclusive, with few or no data for hospitalisation, suicide or all-cause mortality resulting in inconclusive evidence. Expand
Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients.
TLDR
Cognitive-behavioral group therapy is an effective treatment of depression in chronic hemodialysis patients diagnosed with major depression in a randomized trial conducted in Brazil. Expand
Fluoxetine in Depressed Patients on Dialysis
TLDR
This study confirms the relative safety of fluoxetine in depressed patients in renal failure on hemodialysis and suggests that fluoxettine may be efficacious in depressed Patients on dialysis. Expand
Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis.
TLDR
CBT led to significant improvements in depression, quality of life, and prescription compliance in this trial, and studies should be undertaken to assess the long-term effects of CBT on morbidity and mortality in patients with ESRD. Expand
...
1
2
3
4
5
...